Atopic Dermatitis Drugs Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026

Report Code: ZMR-4756 | Report Format : | Status : Upcoming |

Abstract

Global Atopic Dermatitis Drugs Market: Overview

A huge amount of the world’s population is affected by atopic dermatitis (AD), which is a common type of eczema.  Mainly infants and children are mostly affected by atopic dermatitis. The key factor for the market growth is the increasing occurrence of atopic dermatitis. The exact cause for the condition is unknown but it is speculated it may be a result of environmental and genetic factors.

Global Atopic Dermatitis Drugs Market: Growth Factors

Atopic dermatitis drugs market anticipate growing at an average pace. Key drivers for the market growth are an introduction to new biologics and treatments, replacement of primary and second-line therapies with premium-priced drugs, rise in the incidence rates of atopic dermatitis, and improving diagnostics. In recent years, increasing awareness about treatment available for the disease has fuelled market growth. Governments of different regions are taking initiatives to provide affordable treatments to patients and favorable reimbursement policies are triggering further growth of the market. Eucrisa and Dupixent are targeted therapies that are gaining acceptance, which contributes to market growth. Therapeutics cost high thus limiting market development; however, measures are being taken to make the treatment facilities affordable and favorable reimbursement scenarios are also being offered.

 Global Atopic Dermatitis Drugs Market: Segmentation

Broad segmentation of atopic dermatitis drugs market includes the drug class and route of administration. The drug class includes calcineurin inhibitors, biologics, corticosteroids, PDE4 inhibitors, and others. Corticosteroids play a major role in the atopic dermatitis treatment. This drug class is considered as the primary treatment thus corticosteroids segment anticipates holding the majority of the market shares in the upcoming years. In the coming years, the new drug classes PDE4 inhibitors and biologics expect to gain acceptance in the treatment of atopic dermatitis. Based on the route of administration, the market is categorized into oral, injectable, and topical. Topical products anticipate leading the segment. Among the prescribed medications for atopic dermatitis treatment, topical corticosteroids were the widely prescribed ones and they are mainly used in combination with emollients or moisturizers for effective output.

Global Atopic Dermatitis Drugs Market: Regional Analysis

Region-wise, North America anticipates leading the atopic dermatitis market. The U.S. contributes majorly to the North American atopic dermatitis drugs market owing to increasing incidences of atopic dermatitis, high diagnosis rate, and increased awareness, increased healthcare expenditure, favorable reimbursement policies, and increasing initiatives toward introducing new biologic treatments.

Asia Pacific atopic dermatitis drugs market anticipates witnessing a good growth rate in the coming years. Factors contributing to the market growth are growing spendings on healthcare, rise in the unmet patient clinical needs, and the growing research and development activities for introducing effective treatments. Europe is also expected to show a healthy market growth rate in the future, where in the UK and Spain anticipate holding a prominent position.

 Global Atopic Dermatitis Drugs Market: Competitive Players

Industry players in the atopic dermatitis drugs market include Allergan Plc., Bristol-Myers Squibb, Meda Pharmaceuticals, Pfizer, Regeneron Pharmaceuticals, Sanofi SA, Novartis International AG, Bayer AG, Anacor Pharmaceutical Inc., and Astellas Pharma, Inc., among others.

Global Atopic Dermatitis Drugs Market: Regional Segment Analysis

  • North America
    • The U.S.
  • Europe
    • The UK
    • France
    • Germany
  • The Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • The Middle East and Africa

What Reports Provides

  • Full in-depth analysis of the parent market
  • Important changes in market dynamics
  • Segmentation details of the market
  • Former, on-going, and projected market analysis in terms of volume and value
  • Assessment of niche industry developments
  • Market share analysis
  • Key strategies of major players
  • Emerging segments and regional markets
  • Testimonials to companies in order to fortify their foothold in the market.

Related Reports

Hyperhidrosis Treatment Market: By Treatment Type (Botulinum Toxin A, Non-Surgical Microwave Energy Destruction of Sweat Glands, Iontophoresis, Topical Treatments, Surgical Treatments, and Others), By Type (Axillary Hyperhidrosis, Plantar Hyperhidrosis, Palmar Hyperhidrosis, and Others), and By End-User (Hospitals, Ambulatory Surgical Centers, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2019 – 2025

Jan-2020 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-5214 | Report Format:

The report includes Revenue forecast analysis of the hyperhidrosis treatment market on a global as well as regional level. It also offers historic data of 2016 and 2017 and provides a valuation of the industry surge during 2019-2025 in terms of USD Billion. Our study includes competitive strategi...Read More

Home Blood Pressure Monitoring Devices Market: by Product (Upper Arm Monitors, Wrist Monitors, and Accessories), and by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Other Distribution Channels): Global Industry Perspective, Comprehensive Analysis and Forecast, 2019 - 2025

Dec-2019 | Price : $ 4199.00 | Pages: 130 | Report Code: ZMR-5131 | Report Format:

According to the report, global demand for home blood pressure monitoring devices market was valued at USD 1,093.1 million in 2018, and is expected to generate revenue of USD 1,611.3 million by end of 2025, growing at a CAGR of 5.7% between 2019 and 2025 The report covers forecast and analysis f...Read More

Orthostatic Hypotension Drugs Market: by Diagnostic Test Type (ECG, Blood Tests, Stress Test and Other), Drug Type (Midodrine, Northera (droxidopa), Fludrocortisone, Caffeine and Others) and End user (Hospitals, ASCs and Clinics and Others) – Global Industry Perspective Comprehensive Analysis and Forecast, 2019-2025

Dec-2019 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-5123 | Report Format:

The report covers forecast and analysis for the Orthostatic Hypotension Drugs market on a global and regional level. The study provides historic data from 2016 to 2018 along with a forecast from 2019 to 2025 based on revenue (USD Million). The study includes drivers and restraints for the Orthosta...Read More

Carcinoembryonic Antigen Market: by Application (Thyroid Cancer, Prostate Cancer, Ovarian Cancer, Lung Cancer, Breast Cancer, Gastrointestinal Cancer and Other Applications); by End User (Research and Academic Institutes, Diagnostic Centers, Hospitals and Other End Users): Global Industry Perspective, Comprehensive Analysis and Forecast, 2018 - 2025

Dec-2019 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-5122 | Report Format:

The report covers forecast and analysis for the carcinoembryonic antigen market on a global and regional level. The study provides historic data from 2016 along with forecast from 2019 to 2025 based on revenue (USD Million). The study includes drivers and restraints for the carcinoembryonic antige...Read More

Macular Degeneration Treatment Market: by Drug Class (Anti-VEGFs and Other Drugs); by Indication (Wet Age-related Macular Degeneration (wAMD) and Dry Age-related Macular Degeneration (dAMD)); by Distribution Channel (Ambulatory Surgical Centers, Ophthalmic Clinics and Hospitals): Global Industry Perspective, Comprehensive Analysis and Forecast, 2018 - 2025

Nov-2019 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-5117 | Report Format:

The report covers forecast and analysis for the macular degeneration treatment market on a global and regional level. The study provides historic data from 2016 along with forecast from 2019 to 2025 based on revenue (USD Million). The study includes drivers and restraints for the macular degenerat...Read More

Request Brochure
Why Choose Us ?

24/5 Research support

Resolved your research queries from industry expert. Request for a research sample before report purchase.

Custom research service

Ask the Analyst to customize an exclusive study to serve your research needs.

Quality & Accuracy

Zion Market Research reports offers best quality reports based on various authentic and accurate data findings.

Customer Satisfaction

We ensure that our client's all research needs are met with customized, in-depth analysis solutions.

Information security

We never share your personal and confidential information. Your personal information is safe and secure with us.